ArticleClinical parkinsonism & related disorders2022

Efficacy and safety of two incobotulinumtoxinA injection intervals in cervical dystonia patients with inadequate benefit from standard injection intervals of botulinum toxin: Phase 4, open-label, randomized, noninferiority study.

Cynthia Comella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.